The Federal Reserve is still expected to go through with a rate hike. What that means for you
The Federal Reserve is expected to raise interest rates despite a crisis of confidence in the banking industry. Here’s what that means for you.
Morgan Stanley’s Mike Wilson says this is the beginning of the end for the bear market
The bank’s chief investment officer said lending standards will get even tighter, while the cost of deposits will continue to rise.
World’s top climate scientists issue ‘survival guide for humanity,’ call for major course correction
The latest report from the U.N.’s Intergovernmental Panel on Climate Change provides world leaders with a gold-standard summation of modern climate science.
OpenAI-powered app from Microsoft will instantly transcribe patient notes during doctor visits
Microsoft’s Nuance subsidiary are rolling out DAX Express, a clinical notes application for healthcare workers.
Elizabeth Warren says Jerome Powell has ‘failed’ as Federal Reserve chair
“I don’t think he should be chairman of the Federal Reserve,” the Massachusetts Democrat said in an interview on NBC News’ “Meet the Press.”
Taser maker Axon Enterprise shares are up for an eighth-straight year. Here’s what’s driving the gains
In recent years, the company has expanded beyond its flagship Taser weapon into a suite of offerings including body cameras.
Manhattan D.A. says attempts to intimidate office won’t be tolerated after Trump’s call for protests
Alvin Bragg sought to assure staffers in a memo that they’ll be safe.
College acceptance and financial aid letters are going out — how to understand your offers
There is only one notification more significant than being accepted: the college financial aid award letter.
Trump will surrender to face charges if indicted, defense lawyer says
Donald Trump is under criminal investigation for 2016 hush money payment his former attorney Michael Cohen made to porn star Stormy Daniels.
Abortion pill fight: Read the transcript of Texas court hearing on fate of mifepristone
Judge Matthew Kacsmaryk of the U.S. Northern District of Texas heard oral arguments this week in a case challenging FDA approval of mifepristone.
